Glenmark Pharma Shares Slump 1% Despite USFDA Approval
April 9, 2026April 9, 2026 Shares of Glenmark Pharmaceuticals Ltd were trading in the red and 1% lower on Thursday, 9 April, despite the company receiving final approval from the US Food and Drug Administration (USFDA) for its Progesterone Vaginal Inserts, 100 mg, increasing its portfolio in the women’s…